An­oth­er death mars Ab­b­Vie's lat­est batch of promis­ing da­ta for its star rheuma­toid arthri­tis drug

Ab­b­Vie $AB­BV is one step clos­er to achiev­ing its goal of rolling out a close­ly-watched drug for rheuma­toid arthri­tis as the third late-stage study in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA